03.31.14
ZO Skin Health, Inc. is launching its ZO Medical product line to the Middle East region at The Dubai World Dermatology & Laser Conference & Exhibition, which is scheduled for April 8-10, 2014.
“ZO Medical products are the culmination of my decades of research and clinical experience with a unique proven approach to skin care,” said founder Dr. Zein Obagi states. “These products empower physicians to offer patients an even wider choice of innovative treatments for healthy skin within the comprehensive ZO Skin Health Circle. Using superior formulations and unique delivery systems, we can optimize patient results as well as our outcomes.”
ZO Skin Health is working with US-based medical aesthetics firm Cellogique Corporation, which sponsoring the attendance of more than 100 physicians and a surplus of 135 Cellogique team members to the Dubai Derma conference and exhibition.
“We are very excited to bring the highly anticipated ZO Medical line to the Middle East region and make available alongside the ZO Skin Health product line, which has been nothing short of a success,” said Mazen F. Youssef, president and CEO of Cellogique Corporation.
“ZO Medical products are the culmination of my decades of research and clinical experience with a unique proven approach to skin care,” said founder Dr. Zein Obagi states. “These products empower physicians to offer patients an even wider choice of innovative treatments for healthy skin within the comprehensive ZO Skin Health Circle. Using superior formulations and unique delivery systems, we can optimize patient results as well as our outcomes.”
ZO Skin Health is working with US-based medical aesthetics firm Cellogique Corporation, which sponsoring the attendance of more than 100 physicians and a surplus of 135 Cellogique team members to the Dubai Derma conference and exhibition.
“We are very excited to bring the highly anticipated ZO Medical line to the Middle East region and make available alongside the ZO Skin Health product line, which has been nothing short of a success,” said Mazen F. Youssef, president and CEO of Cellogique Corporation.